{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:08:12Z","timestamp":1790428092558,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.canrad.2014.12.010","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T20:36:26Z","timestamp":1428266186000},"page":"211-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u00c9tat des lieux et perspectives de la protonth\u00e9rapie"],"prefix":"10.1016","volume":"19","author":[{"given":"J.","family":"Doyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-Y.","family":"Bondiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"B\u00e9n\u00e9z\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-\u00c8.","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Leysalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Habrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Hannoun-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2014.12.010_bib0005","series-title":"Plan cancer 2014\u20132019","author":"Anon","year":"2014"},{"key":"10.1016\/j.canrad.2014.12.010_bib0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2014.12.010_bib0015","series-title":"Particle therapy facilities in operation [base de donn\u00e9es sur Internet]. Villigen PSI: Particle Therapy Cooperative Group","author":"Particle Therapy Cooperative Group","year":"2014"},{"key":"10.1016\/j.canrad.2014.12.010_bib0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.canrad.2013.07.141","article-title":"\u00c9volution des indications cliniques en hadronth\u00e9rapie 2008\u20132012","volume":"17","author":"Habrand","year":"2013","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.canrad.2014.12.010_bib0025","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2014.04.029","article-title":"Involved node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2\u00a0study","volume":"89","author":"Hoppe","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1748-717X-8-93","article-title":"Reirradiation of recurrent head and neck carcinomas: comparison of robust intensity-modulated proton therapy treatment plans with helical tomotherapy","volume":"8","author":"Stuschke","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0035","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ijrobp.2010.05.012","article-title":"Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer","volume":"79","author":"van de Water","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ijrobp.2014.04.019","article-title":"Multifield optimization intensity-modulated proton therapy for head and neck tumors: a translation to practice","volume":"89","author":"Frank","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2008.05.065","article-title":"Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation","volume":"72","author":"Widesott","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1470-2045(14)70268-2","article-title":"Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis","volume":"15","author":"Patel","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1078\/0939-3889-00217","article-title":"The clinical potential of intensity-modulated proton therapy","volume":"14","author":"Lomax","year":"2004","journal-title":"Z Med Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","article-title":"Methodologies and tools for proton beam design for lung tumors","volume":"49","author":"Moyers","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2011.02.014","article-title":"Dose escalation for non-small cell lung cancer: analysis and modelling of published literature","volume":"99","author":"Partridge","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0075","first-page":"348","article-title":"Accelerated dose escalation with proton beam therapy for non-small cell lung cancer","volume":"6","author":"Gomez","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.canrad.2014.12.010_bib0080","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2006.01.052","article-title":"Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer","volume":"65","author":"Chang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7785\/tcrt.2012.500208","article-title":"Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer","volume":"10","author":"Nichols","year":"2011","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2014.12.010_bib0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1748-717X-8-144","article-title":"An in silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer","volume":"8","author":"Berman","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0095","first-page":"S3","article-title":"An intergroup randomized phase III comparison of standard-dose (60Gy) vs high-dose (74Gy) chemoradiotherapy (CRT)\u00b1cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): results on cetux from RTOG 0617","volume":"8","author":"Bradley","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0100","first-page":"2","article-title":"Highlights in NSCLC From the 15th World Conference on Lung Cancer","volume":"12","author":"Anon","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0105","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2014.07.045","article-title":"Clinical implementation of intensity-modulated proton therapy for thoracic malignancies","volume":"90","author":"Chang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0110","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801\u00a0women in 17\u00a0randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2014.12.010_bib0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00066-006-1534-8","article-title":"The impact of IMRT and proton radiotherapy on secondary cancer incidence","volume":"182","author":"Schneider","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1748-717X-8-71","article-title":"Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery","volume":"8","author":"MacDonald","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.03.028","article-title":"Intensity-modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study","volume":"107","author":"Jimenez","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0135","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijrobp.2013.01.038","article-title":"Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial","volume":"86","author":"MacDonald","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0140","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/JTO.0b013e3182199819","article-title":"Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined modality treatment of malignant pleural mesothelioma","volume":"6","author":"Chi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00066-011-0038-3","article-title":"Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment","volume":"188","author":"Lorentini","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the \u201cSMART\u201d approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0155","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1016\/j.ijrobp.2011.02.041","article-title":"Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma","volume":"81","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0160","first-page":"374","article-title":"Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers","volume":"4","author":"Lee","year":"2013","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0165","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijrobp.2014.03.034","article-title":"A phase 1\/2\u00a0and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma","volume":"89","author":"Hong","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijrobp.2011.05.045","article-title":"Protons offer reduced normal tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer","volume":"83","author":"Nichols","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0175","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.15_suppl.4001","article-title":"Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP-07\u00a0study","volume":"32","author":"Huguet","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0180","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1002\/cncr.24572","article-title":"Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis","volume":"115","author":"Fuller","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.12.010_bib0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-9-26","article-title":"Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma","volume":"9","author":"Makita","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-8-48","article-title":"What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy","volume":"8","author":"Toramatsu","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0195","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting radiotherapy in early positron emission tomography-negative stage I\/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC\/LYSA\/FIL H10\u00a0trial","volume":"32","author":"Raemaekers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0200","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pbc.24861","article-title":"The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma","volume":"61","author":"Maraldo","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.canrad.2014.12.010_bib0205","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0210","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/annonc\/mdr616","article-title":"Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis","volume":"23","author":"Choi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0215","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00066-013-0432-0","article-title":"Small bowel toxicity after high-dose spot-scanning-based proton beam therapy for paraspinal\/retroperitoneal neoplasms","volume":"189","author":"Schneider","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0360-3016(95)00063-5","article-title":"Advanced prostate cancer: the results of a randomized comparative trial of high-dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone","volume":"32","author":"Shipley","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0225","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijrobp.2013.08.027","article-title":"Intensity-modulated proton beam radiation for brachytherapy in patients with cervical carcinoma","volume":"87","author":"Clivio","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0230","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2013.11.241","article-title":"Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon ion therapy and high-dose-rate or low-dose-rate brachytherapy","volume":"88","author":"Georg","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0235","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2014.07.032","article-title":"Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy","volume":"90","author":"Hamilton","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0240","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2013.09.038","article-title":"Proton therapy for reirradiation of progressive or recurrent chordoma","volume":"87","author":"McDonald","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.010_bib0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2013.08.014","article-title":"Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer","volume":"109","author":"McAvoy","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0250","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00066-013-0390-6","article-title":"Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution","volume":"189","author":"Mizumoto","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0260","doi-asserted-by":"crossref","first-page":"107646","DOI":"10.1155\/2013\/107646","article-title":"Epidemiological study of the incidence of cancers eligible for proton or carbon ions therapy: methodology and results of recruitment estimation","volume":"2013","author":"Patin","year":"2013","journal-title":"J Cancer Epidemiol"},{"key":"10.1016\/j.canrad.2014.12.010_bib0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1748-717X-7-33","article-title":"Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer","volume":"7","author":"Amini","year":"2012","journal-title":"Radiat Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:23:02Z","timestamp":1761135782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321815000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1278321815000359"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2014.12.010","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tat des lieux et perspectives de la protonth\u00e9rapie","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}